Del100 and del231 were originally identified while studying the impact of NMD on hereditary tyrosinemia type I. During the characterization of the effects of the W262X mutation on FAH mRNA metabolism [29], we detected two minor alternative transcripts. The gene discussed is FAH; the disease is tyrosinemia type I.